Richard B. Horenstein

4.2k citations

27 papers · 1.8k indexed · 1 hit paper · h-index 20

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Treatment and Management 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
Cardiology and Cardiovascular Medicine top 5%
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Lipid metabolism and disorders 5
Biochemistry top 5%
Cancer Research top 10%
Surgery top 5%
- Lipoproteins and Cardiovascular Health 5
Pharmacology
- Inflammatory mediators and NSAID effects 4
- Pharmacology and Obesity Treatment 3
Genetics
- Genetic Associations and Epidemiology 2

Co-authors: Alan R. Shuldiner Toni I. Pollin Braxton D. Mitchell Jeffrey R. O’Connell Coleen Damcott John C. McLenithan Wendy S. Post Patricia A. Peyser
Cited by: Endocrinology, Diabetes and Metabolism Cardiology and Cardiovascular Medicine Biochemistry
Journals: Pharmacogenetics and Genomics (3 papers)Journal of the American Heart Association (2 papers)Endocrine Practice (2 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Richard B. Horenstein

27 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Richard B. Horenstein

Since Specialization

Citations

This map shows the geographic impact of Richard B. Horenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Horenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Horenstein more than expected).

Fields of papers citing papers by Richard B. Horenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Horenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Horenstein. The network helps show where Richard B. Horenstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard B. Horenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard B. Horenstein Line = papers co-authored together Richard B. Horenstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genome-wide association analysis of common genetic variants of resistant hypertension The Pharmacogenomics Journal ·(unknown),Nihal El Rouby,Caitrin W. McDonough,Yan Gong,Leslie A. McClure,Braxton D. Mitchell,Richard B. Horenstein,Robert L. Talbert,Dana C. Crawford,Matthew A. Gitzendanner,Atsushi Takahashi,Toshihiro Tanaka,Michiaki Kubo,Carl J. Pepine,Rhonda M. Cooper‐DeHoff,Oscar Benavente,Alan R. Shuldiner,Julie A. Johnson	2018	16
2	Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response Pharmacogenetics and Genomics ·Joshua Backman,Jeffrey R. O’Connell,Keith Tanner,Cody J. Peer,William D. Figg,Shawn D. Spencer,Braxton D. Mitchell,Alan R. Shuldiner,Laura M. Yerges‐Armstrong,Richard B. Horenstein,Joshua P. Lewis	2017	19
3	A systematic analysis and comparison of warfarin initiation strategies Pharmacogenetics and Genomics ·Benjamin French,Le Wang,Brian F. Gage,Richard B. Horenstein,Nita A. Limdi,Stephen E. Kimmel	2016	5
4	Oxylipid Profile of Low‐Dose Aspirin Exposure: A Pharmacometabolomics Study Journal of the American Heart Association ·Sandrine Ellero‐Simatos,Amber L. Beitelshees,Joshua P. Lewis,Laura M. Yerges‐Armstrong,Anastasia Georgiades,Adrie Dane,Amy C. Harms,Katrin Strassburg,Jose Nuñez Liñan,Margriet M. W. B. Hendriks,Richard B. Horenstein,Alan R. Shuldiner,Thomas Hankemeier,Rima Kaddurah‐Daouk	2015	21
5	The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin Current Vascular Pharmacology ·Morag M. Brown,Braxton D. Mitchell,Joshua P. Lewis,Kathleen A. Ryan,William R. Herzog,Jeffrey R. O’Connell,Richard B. Horenstein,Alan R. Shuldiner,Laura M. Yerges‐Armstrong	2015	11
6	The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing American Journal of Cardiovascular Drugs ·Scott E. Kasner,Le Wang,Benjamin French,Steven R. Messé,Richard B. Horenstein,Emile R. Mohler,James A.S. Muldowney,Jonas H. Ellenberg,Stephen E. Kimmel	2015	1
7	Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults European Journal of Pharmaceutical Sciences ·Xiling Jiang,L. Giglioli,Joshua P. Lewis,Richard B. Horenstein,Alan R. Shuldiner,Laura M. Yerges‐Armstrong,L. A. Peletier,Lawrence J. Lesko,Stephan Schmidt	2015	24
8	CYP2C19 Metabolizer Status and Clopidogrel Efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) Study Journal of the American Heart Association ·Caitrin W. McDonough,Leslie A. McClure,Braxton D. Mitchell,Yan Gong,Richard B. Horenstein,Joshua P. Lewis,Thalia S. Field,Robert L. Talbert,Oscar Benavente,Julie A. Johnson,Alan R. Shuldiner	2015	47
9	Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes New England Journal of Medicine ·M.G. Kim,Laura M. Yerges‐Armstrong,Richard B. Horenstein,Toni I. Pollin,Urmila Sreenivasan,C ONWUEGBUKE,William S. Blaner,Søren Snitker,Jeffrey R. O’Connell,Biswajit Mohapatra,Richard J. Breyer,Alice S. Ryan,John C. McLenithan,Alan R. Shuldiner,Carole Sztalryd,Coleen Damcott	2014	151
10	Pharmacogenomics of Anti-platelet and Anti-coagulation Therapy Current Cardiology Reports ·Adam S. Fisch,Katharine I. Kalamaroff,Sarah H. Stephens,Richard B. Horenstein,Alan R. Shuldiner	2013	7
11	Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome PLoS ONE ·Margaret L. Zupancic,Brandi L. Cantarel,Zhenqiu Liu,Elliott F. Drábek,Kathleen A. Ryan,In Joo Cho,M. Haki Yakar,Rob Knight,William A. Walters,K Bischops,Emmanuel F. Mongodin,Richard B. Horenstein,Braxton D. Mitchell,Nanette Steinle,Søren Snitker,Alan R. Shuldiner,Claire M. Fraser	2012	160
12	The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response Pharmacogenetics and Genomics ·Joshua P. Lewis,Richard B. Horenstein,Kathleen A. Ryan,Jeffrey R. O’Connell,Quince Gibson,Braxton D. Mitchell,Keith Tanner,C ONWUEGBUKE,Kevin P. Bliden,Udaya S. Tantry,Cody J. Peer,William D. Figg,Shawn D. Spencer,Michael Pacanowski,Paul A. Gurbel,Alan R. Shuldiner	2012	129
13	The ABCG8 G574R Variant, Serum Plant Sterol Levels, and Cardiovascular Disease Risk in the Old Order Amish Arteriosclerosis Thrombosis and Vascular Biology ·Richard B. Horenstein,Braxton D. Mitchell,Wendy S. Post,Dieter Lütjohann,Klaus von Bergmann,Kathleen A. Ryan,Michael Terrin,Alan R. Shuldiner,Nanette Steinle	2012	26
14	A sensitive and rapid ultra HPLC–MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma Journal of Chromatography B ·Cody J. Peer,Shawn D. Spencer,Tahereh Manouchehri,Michael Pacanowski,Richard B. Horenstein,William D. Figg	2011	44
15	Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish Archives of Internal Medicine ·Haiqing Shen,Coleen Damcott,Evadnie Rampersaud,Toni I. Pollin,Richard B. Horenstein,Patrick F. McArdle,Patricia A. Peyser,Lawrence F. Bielak,Wendy S. Post,Yen-Pei C. Chang,Kathleen A. Ryan,Michael Miller,John A. Rumberger,Patrick F. Sheedy,John C. Shelton,Jeffrey R. O’Connell,Alan R. Shuldiner,Braxton D. Mitchell	2010	55
16	A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotectionbreakdown → Science ·Toni I. Pollin,Coleen Damcott,Haiqing Shen,Sandra Ott,John C. Shelton,Richard B. Horenstein,Wendy S. Post,John C. McLenithan,Lawrence F. Bielak,Patricia A. Peyser,Braxton D. Mitchell,Michael Miller,Jeffrey R. O’Connell,Alan R. Shuldiner	2008	517
17	Two Cases of Thyroid Storm-Associated Cholestatic Jaundice Endocrine Practice ·Heather Hazlett,Richard B. Horenstein,Fauzul Kabir,Kashif M. Munir,Marc G. Ghany,Francesco S. Celi	2007	39
18	Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications PLoS Medicine ·Rongze Yang,Mi‐Jeong Lee,Hong Hu,Toni I. Pollin,Alice S. Ryan,Barbara J. Nicklas,Søren Snitker,Richard B. Horenstein,Heather Hazlett,Nelson H. Goldberg,Andrew P. Goldberg,Alan R. Shuldiner,Susan K. Fried,Da‐Wei Gong	2006	278
19	Adrenal Cortical Adenoma with Excess Black Pigment Deposition, Combined with Myelolipoma and Clinical Cushing's Syndrome International Journal of Surgical Pathology ·Ray Armand,Anne Rentoumis Cappola,Richard B. Horenstein,Cinthia B. Drachenberg,Hironobu Sasano,John C. Papadimitriou	2004	13
20	New progress in adipocytokine research Current Opinion in Endocrinology & Diabetes ·Da‐Wei Gong,Rongze Yang,Kashif M. Munir,Richard B. Horenstein,Alan R. Shuldiner	2003	19

About Richard B. Horenstein

Richard B. Horenstein is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Lipoproteins and Cardiovascular Health (5 papers), Lipid metabolism and disorders (5 papers), Diabetes Treatment and Management (4 papers), Inflammatory mediators and NSAID effects (4 papers), Pharmacology and Obesity Treatment (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Genetic Associations and Epidemiology (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (554 citations), Cardiology and Cardiovascular Medicine (634 citations) and Biochemistry (126 citations). Richard B. Horenstein has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Alan R. Shuldiner, Toni I. Pollin, Braxton D. Mitchell, Jeffrey R. O’Connell, Coleen Damcott, John C. McLenithan, Wendy S. Post, Patricia A. Peyser, Lawrence F. Bielak and Michael Miller. Their work appears in journals such as Pharmacogenetics and Genomics, Journal of the American Heart Association, Endocrine Practice, Arteriosclerosis Thrombosis and Vascular Biology and Stroke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact